What is AirXpanders?
AirXpanders operates as a specialized entity focused on high-growth potential within its sector. By leveraging a combination of equity financing, debt instruments, and strategic share placements, the company has built a robust foundation for development. Its market position is characterized by a disciplined approach to asset management and a commitment to operational efficiency, allowing it to transition from early-stage development into a more mature, enterprise-level organization. The firm's ability to attract diverse capital sources reflects its resilience and adaptability in fluctuating economic environments.
How much funding has AirXpanders raised?
AirXpanders has raised a total of $162.5M across 12 funding rounds:
Series D
$10M
Series E
$4M
Debt
$7M
Other Financing Round
$1M
Stock Offering
$36.5M
Share Placement
$15M
Share Placement
$34M
Debt
$15M
Other Financing Round
$15M
Series D (2012): $10M featuring Western Technology Investment, Prolog Ventures, Vivo Ventures, GBS Venture Partners, and Heron Capital
Series E (2013): $4M backed by GBS Venture Partners
Debt (2014): $7M with participation from GE Capital
Other Financing Round (2014): $1M led by GBS Venture Partners and Heron Capital
Stock Issuance/Offering (2015): $36.5M, investors not publicly disclosed
Share Placement (2016): $15M, investors not publicly disclosed
Share Placement (2017): $34M, investors not publicly disclosed
Debt (2017): $15M with participation from Oxford Finance
Other Financing Round (2018): $15M led by Vivo Ventures
Key Investors in AirXpanders
GBS Venture Partners
GBS Venture Partners is a venture capital firm that focuses on investing in innovative healthcare companies. They aim to support entrepreneurs in the development of groundbreaking medical solutions.
Oxford Finance Corporation
Oxford Finance founded in 2002 and headquartered in Alexandria, Virginia, is a specialty finance firm that offers flexible financial solutions to healthcare and life sciences companies worldwide.
Vivo Ventures
Vivo Capital founded in 1996 and headquartered in Palo Alto, California, is a global healthcare investment firm focused on private and public equity as well as venture capital.
What's next for AirXpanders?
Looking ahead, AirXpanders is positioned to utilize its recent capital injection to accelerate its strategic initiatives. The focus remains on optimizing performance metrics and exploring opportunistic growth avenues that align with its long-term vision. By maintaining a lean operational structure and leveraging the expertise of its seasoned investor base, the company is well-equipped to navigate future market challenges. The strategic deployment of these funds will likely prioritize sustainable growth, ensuring that the firm remains a competitive force while delivering value to its stakeholders through continued innovation and operational excellence.
See full AirXpanders company page
